Jeffrey Humphrey
Director Técnico/Científico/I+D en LANTHEUS HOLDINGS, INC. .
Fortuna: - $ al 31/03/2024
Cargos activos de Jeffrey Humphrey
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| LANTHEUS HOLDINGS, INC. | Director Técnico/Científico/I+D | 28/05/2024 | - |
Historial de carrera de Jeffrey Humphrey
Antiguos cargos conocidos de Jeffrey Humphrey.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Director/Miembro de la Junta | 15/12/2021 | 29/11/2023 |
| Independent Dir/Board Member | 15/12/2021 | 29/11/2023 | |
| MAGENTA THERAPEUTICS | Director Técnico/Científico/I+D | 04/10/2021 | 01/08/2022 |
| CONSTELLATION PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 22/06/2020 | 15/07/2021 |
| KYOWA KIRIN CO. LTD. | Corporate Officer/Principal | 01/08/2019 | 01/06/2020 |
Kyowa Kirin Pharmaceutical Development Ltd.
 Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom. | Director Técnico/Científico/I+D | 01/04/2013 | 01/08/2019 |
| Presidente | 01/04/2013 | 01/08/2019 | |
| Kyowa Hakko Kirin Pharma, Inc. | Corporate Officer/Principal | 01/04/2012 | 01/03/2013 |
Formación de Jeffrey Humphrey.
| Harvard College | Undergraduate Degree |
| Case Western Reserve University School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
| Japón | 2 |
| Reino Unido | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| KYOWA KIRIN CO. LTD. | Health Technology |
| LANTHEUS HOLDINGS, INC. | Health Technology |
| CYTEIR THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
| Kyowa Hakko Kirin Pharma, Inc. | |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Kyowa Kirin Pharmaceutical Development Ltd.
Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom. | Commercial Services |
- Bolsa de valores
- Insiders
- Jeffrey Humphrey
- Experiencia
